+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology (ISH, Digital Pathology), By Application (Breast Cancer, Prostate Cancer), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 4751821
The global tissue diagnostics market size is expected to reach USD 8.99 billion by 2030, growing at 7.15% CAGR from 2023 to 2030. Accelerating demand for automated tissue diagnostic systems due to a lack of skilled pathologists has driven the tissue diagnostics industry. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplements the market growth.

The use of digital slides has significantly increased in recent years, owing to its associated benefits including flexible magnification and remote access to slides. The growing emphasis on precision medicine is supported by several organizations & companies in the U. S., which is expected to contribute to the market growth. Additionally, companies are supporting the development of precision medicine with novel oncology solutions. For instance, in May 2020, QIAGEN launched new oncology solutions, such as the QCI Interpret One software solution for genomic profiling of tumors. The advancements in imaging techniques are expected to positively influence market growth.

In addition, one of the emerging trends in the tissue diagnostics industry is the integration of digital pathology and artificial intelligence (AI). Digital pathology involves the scanning and digitization of tissue slides, allowing pathologists to review and analyze images remotely. AI algorithms can then be applied to these digital images to aid in the interpretation and analysis of tissue samples. This integration enables faster and more accurate diagnoses, enhances workflow efficiency, and improves patient care. It also facilitates the development of predictive models and precision medicine approaches. As a result, there is a growing demand for digital pathology solutions and AI-driven tissue diagnostics platforms in the market.

With technological improvements in imaging techniques, the sensitivity of detection and diagnosis of breast cancer has also improved. For instance, in May 2023, with an emphasis on AI-guided breast cancer diagnoses, BPGbio recently announced an agreement with the Department of Defense (DoD). The new panel, created with artificial intelligence, is intended to detect women diagnosed with ER+ breast cancer but do not react to hormone therapy, allowing for more suitable treatment alternatives and improving treatment response.

The unique 34-gene breast cancer diagnostic panel from BPGbio will also receive wider evaluation through the Interrogative Biology Platform, focusing on ER+ breast cancers, which are significantly rising. Technological expansion in breast tissue analysis includes procedures for evaluating gene expression, cellular biochemistry, and molecular biology using digital methods, tomosynthesis, CAD, and other methods.

Tissue Diagnostics Market Report Highlights

  • The IHC segment held the largest share of the tissue diagnostics industry in 2022. IHC tests are highly adopted as these tests provide precision and help identify the variations between different types of cancer, resulting in the largest revenue share
  • The digital pathology and workflow segment is expected to grow at the fastest CAGR during the study period. A rise in investments in the development of advanced infrastructure to digitalize images is anticipated to drive the digital pathology segment. Moreover, an increase in the demand for automated modalities owing to a dearth of skilled pathologists further compliments this growth
  • A large number of breast cancer cases coupled with a rise in the application of digital image processing techniques on histopathological samples for breast cancer detection contributes to the largest share of the tissue diagnostics industry
  • The hospital segment dominated the tissue diagnostics industry in 2022 due to the high adoption of tissue diagnostics solutions. These solutions provide more accurate results in minimal time than conventional testing procedures
  • North America accounted for the largest revenue share of the tissue diagnostics industry in 2022 owing to increasing collaborations between pharmaceutical and biotech firms to expand their product offerings
  • Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the market. Key vendors are engaged in novel product developments, partnerships, and acquisition models to maintain their revenue share in the market


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Tissue Diagnostics Market

What is the estimated value of the Global Tissue Diagnostics Market?

The Global Tissue Diagnostics Market was estimated to be valued at $5.19 Billion in 2022.

What is the growth rate of the Global Tissue Diagnostics Market?

The growth rate of the Global Tissue Diagnostics Market is 7.1%, with an estimated value of $8.99 Billion by 2030.

What is the forecasted size of the Global Tissue Diagnostics Market?

The Global Tissue Diagnostics Market is estimated to be worth $8.99 Billion by 2030.

Who are the key companies in the Global Tissue Diagnostics Market?

Key companies in the Global Tissue Diagnostics Market include F. Hoffmann, La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens, Danaher Corporation, bioMerieux SA, QIAGEN, BD and Merck KGaA.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Application Segment
1.1.1.2. Technology Segment
1.1.1.3. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.3.1. Objectives
1.3.2. Objective - 1
1.3.3. Objective - 2
1.3.4. Objective - 3
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Technology & Application Snapshot
2.3. End-use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Worldwide increase in cancer prevalence
3.2.1.2. Advancements in imaging techniques and increasing affordability of diagnostics
3.2.1.3. Growth of personalized therapeutics and diagnostics
3.2.2. Market Restraint Analysis
3.2.2.1. High costs associated with R&D and clinical trials
3.2.2.2. Presence of a non-value-based reimbursement policy
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Technology Business Analysis
4.1. Tissue Diagnostics Market: Technology Movement Analysis
4.2. Immunohistochemistry
4.2.1. Immunohistochemistry Market, 2018 - 2030 (USD Million)
4.2.2. Instruments
4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.2.2.2. Slide Staining Systems
4.2.2.2.1. Slide Staining Systems Market, 2018 - 2030 (USD Million)
4.2.2.3. Tissue Microarrays
4.2.2.3.1. Tissue Microarrays Market, 2018 - 2030 (USD Million)
4.2.2.4. Tissue Processing Systems
4.2.2.4.1. Tissue Processing Systems Market, 2018 - 2030 (USD Million)
4.2.2.5. Slide Scanners
4.2.2.5.1. Slide Scanners Market, 2018 - 2030 (USD Million)
4.2.2.6. Other Products
4.2.2.6.1. Other Products Market, 2018 - 2030 (USD Million)
4.2.3. Consumables
4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.2.3.2. Antibodies
4.2.3.2.1. Antibodies Market, 2018 - 2030 (USD Million)
4.2.3.3. Reagents
4.2.3.3.1. Reagents Market, 2018 - 2030 (USD Million)
4.2.3.4. Kits
4.2.3.4.1. Kits Market, 2018 - 2030 (USD Million)
4.3. In situ Hybridization
4.3.1. In situ Hybridization Market, 2018 - 2030 (USD Million)
4.3.2. Instruments
4.3.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3.3. Consumables
4.3.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.3.4. Software
4.3.4.1. Software Market, 2018 - 2030 (USD Million)
4.4. Primary & Special Staining
4.4.1. Primary & Special Staining Market, 2018 - 2030 (USD Million)
4.5. Digital Pathology & Workflow
4.5.1. Digital Pathology & Workflow Market, 2018 - 2030 (USD Million)
4.5.2. Whole Slide Imaging
4.5.2.1. Whole Slide Imaging Market, 2018 - 2030 (USD Million)
4.5.3. Image Analysis Informatics
4.5.3.1. Image Analysis Informatics Market, 2018 - 2030 (USD Million)
4.5.4. Information Management System Storage & Communication
4.5.4.1. Information Management System Storage & Communication Market, 2018 - 2030 (USD Million)
4.6. Anatomic Pathology
4.6.1. Anatomic Pathology Market, 2018 - 2030 (USD Million)
4.6.2. Instruments
4.6.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.6.2.2. Microtomes & Cryostat Microtomes
4.6.2.2.1. Microtomes & Cryostat Microtomes Market, 2018 - 2030 (USD Million)
4.6.2.3. Tissue Processors
4.6.2.3.1. Tissue Processors Market, 2018 - 2030 (USD Million)
4.6.2.4. Automatic Strainers
4.6.2.4.1. Automatic Strainers Market, 2018 - 2030 (USD Million)
4.6.2.5. Other Products
4.6.2.5.1. Other Products Market, 2018 - 2030 (USD Million)
4.6.3. Consumables
4.6.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.6.3.2. Antibodies & Reagents
4.6.3.2.1. Antibodies & Reagents Market, 2018 - 2030 (USD Million)
4.6.3.3. Probes & Kits
4.6.3.3.1. Probes & Kits Market, 2018 - 2030 (USD Million)
4.6.3.4. Others
4.6.3.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Tissue Diagnostics Market: Application Movement Analysis
5.2. Breast Cancer
5.2.1. Breast Cancer Market, 2018 - 2030 (USD Million)
5.3. Non-Small Cell Lung Cancer
5.3.1. Non-Small Cell Lung Cancer Market, 2018 - 2030 (USD Million)
5.4. Other Cancers
5.4.1. Other Cancers Technology Market, 2018 - 2030 (USD Million)
5.5. Gastric Cancer
5.5.1. Gastric Cancer Technology Market, 2018 - 2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. Hospitals
6.1.1. Hospitals Market, 2018 - 2030 (USD Million)
6.2. Research Laboratories
6.2.1. Research Laboratories Market, 2018 - 2030 (USD Million)
6.3. Pharmaceutical Organizations
6.3.1. Pharmaceutical Organizations Market, 2018 - 2030 (USD Million)
6.4. CRO
6.4.1. CRO Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Tissue Diagnostics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Spain Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.6. France
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. France Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.7. Italy
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Italy Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. South Korea Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4.7. Singapore
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Singapore Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4.8. Australia
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Australia Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.4.9. Thailand
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Regulatory Framework
7.4.9.5. Thailand Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. UAE Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.6.5. Saudi Arabia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Saudi Arabia Tissue Diagnostics Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Tissue Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. F. Hoffmann-La Roche Ltd.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Technology Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Abbott Laboratories
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Technology Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Thermo Fisher Scientific, Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Technology Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Siemens
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Technology Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Danaher Corporation
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Technology Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. bioMerieux SA
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Technology Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. QIAGEN
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Technology Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. BD
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Technology Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Merck KGaA
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Technology Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. GE Healthcare
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Technology Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. BioGenex
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Technology Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Cell Signaling Technology, Inc.
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Technology Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Bio SB
8.4.13.1. Overview
8.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.13.3. Technology Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. DiaGenic ASA
8.4.14.1. Overview
8.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.14.3. Technology Benchmarking
8.4.14.4. Strategic Initiatives
8.4.15. Agilent Technologies, Inc
8.4.15.1. Overview
8.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.15.3. Technology Benchmarking
8.4.15.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 3 North America Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 4 North America Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 5 North America tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 7 U.S. Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 8 U.S. Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 9 Canada Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 10 Canada Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 11 Canada Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 12 Europe Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 13 Europe Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 14 Europe Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 15 Europe tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 16 UK Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 17 UK Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 18 UK Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 19 Germany Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 20 Germany Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 21 Germany Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 22 Spain Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 23 Spain Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 24 Spain Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 25 France Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 26 France Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 27 France Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 28 Italy Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 29 Italy Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 30 Italy Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 31 Denmark Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 32 Denmark Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 33 Denmark Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 34 Sweden Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 35 Sweden Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 36 Sweden Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 37 Norway Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 38 Norway Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 39 Norway Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 44 Japan Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 45 Japan Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 46 Japan Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 47 China Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 48 China Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 49 China Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 50 India Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 51 India Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 52 India Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 53 South Korea Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 54 South Korea Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 55 South Korea Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 56 Singapore Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 57 Singapore Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 58 Singapore Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 59 Australia Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 60 Australia Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 61 Australia Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 62 Thailand Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 63 Thailand Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 64 Thailand Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 65 Latin America Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 66 Latin America Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 67 Latin America Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 68 Latin America tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 69 Brazil Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 70 Brazil Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 71 Brazil Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 72 Mexico Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 73 Mexico Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 74 Mexico Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 75 Argentina Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 76 Argentina Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 77 Argentina Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 79 Middle East and Africa Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 80 Middle East and Africa Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 81 Middle East and Africa tissue diagnostics market, by region, 2018 - 2030 (USD Million)
Table 82 South Africa Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 83 South Africa Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 84 South Africa Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 88 UAE Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 89 UAE Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 90 UAE Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 91 Kuwait Tissue Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
Table 92 Kuwait Tissue Diagnostics Market, by Application, 2018 - 2030 (USD Million)
Table 93 Kuwait Tissue Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Segmentation & Scope
Fig. 2 Market summary
Fig. 3 Market research process
Fig. 4 Data triangulation techniques
Fig. 5 Primary research pattern
Fig. 6 Market research approaches
Fig. 7 Value chain-based sizing & forecasting
Fig. 8 QFD modeling for market share assessment
Fig. 9 Market Formulation & Validation
Fig. 10 Market Trends & Outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Global cancer incidence, as of 2023
Fig. 13 Approved New Molecular Entities (NMEs) in 2022
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Penetration & growth prospect mapping for applications, 2022
Fig. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 Global tissue diagnostics market: Technology outlook key takeaways
Fig. 19 Global tissue diagnostics market: Technology movement analysis
Fig. 20 Global immunohistochemistry for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 21 Global immunohistochemistry instruments for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 22 Global immunohistochemistry slide staining systems for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 23 Global immunohistochemistry tissue microarrays for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 24 Global immunohistochemistry tissue processing systems for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 25 Global immunohistochemistry slide scanners for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 26 Global immunohistochemistry other Products for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 27 Global immunohistochemistry consumables for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 28 Global immunohistochemistry reagents for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 29 Global immunohistochemistry antibodies for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 30 Global immunohistochemistry kits for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 31 Global in-situ hybridization for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 32 Global in-situ hybridization instruments for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 33 Global in-situ hybridization consumables for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 34 Global in-situ hybridization software for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 35 Global primary & special staining for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 36 Key drivers for digital pathology
Fig. 37 Global digital pathology & workflow for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 38 Global digital pathology & workflow whole slide imaging for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 39 Global digital pathology & workflow image analysis informatics for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 40 Global digital pathology & workflow information management system storage & communication for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 41 Global anatomic pathology for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 42 Global anatomic pathology instruments for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 43 Global anatomic pathology microtomes & cryostat for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 44 Global anatomic pathology tissue processors for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 45 Global anatomic pathology automatic strainers for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 46 Global other anatomic pathology instruments for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 47 Global anatomic pathology consumables for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 48 Global anatomic pathology reagents & antibodies for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 49 Global anatomic pathology kits & probes for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 50 Global other anatomic pathology consumables for tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 51 Global tissue diagnostics market: Application outlook key takeaways
Fig. 52 Global tissue diagnostics market: Application movement analysis
Fig. 53 Global tissue-based breast cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 54 Global tissue-based NSCLC diagnostics market, 2018 - 2030 (USD Million)
Fig. 55 Global tissue-based prostate cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 56 Global tissue-based gastric cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 57 Global tissue-based other cancer diagnostics market, 2018 - 2030 (USD Million)
Fig. 58 Global tissue diagnostics market: End-use category outlook key takeaways
Fig. 59 Global tissue diagnostics market: End-use category movement analysis
Fig. 60 Regional distribution of hospitals, by funding body (2018)
Fig. 61 Global hospital-based tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 62 Global research laboratories market, 2018 - 2030 (USD Million)
Fig. 63 Global pharmaceutical organizations market, 2018 - 2030 (USD Million)
Fig. 64 Clinical trials for cancer (including neoplasm and tumor)
Fig. 65 Global CROs-based tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 66 Tissue diagnostics regional market: Key takeaways
Fig. 67 Tissue diagnostics regional outlook, 2022 & 2030
Fig. 68 North America tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 69 U.S. tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 70 Canada tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 71 Europe tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 72 UK tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 73 Germany tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 74 Spain tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 75 France tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 76 Italy tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 77 Denmark tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 78 Sweden tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 79 Norway tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 80 Asia Pacific tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 81 Japan tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 82 China tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 83 India tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 84 South Korea tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 85 Singapore tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 86 Australia tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 87 Thailand tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 88 Latin America tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 89 Brazil tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 90 Mexico tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 91 Argentina tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 92 Middle East & Africa tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 93 South Africa tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 94 Saudi Arabia tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 95 UAE tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 96 Kuwait tissue diagnostics market, 2018 - 2030 (USD Million)
Fig. 97 Participant categorization
Fig. 98 Impact analysis by key companies
Fig. 99 Market Position analysis for public Companies
Fig. 100 Strategy framework

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Siemens
  • Danaher Corporation
  • bioMerieux SA
  • QIAGEN
  • BD
  • Merck KGaA
  • GE Healthcare
  • BioGenex
  • Cell Signaling Technology, Inc.
  • Bio SB
  • DiaGenic ASA
  • Agilent Technologies, Inc

Methodology

Loading
LOADING...